Back to Top Craig C. Hofmeister, MD, MPH | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Craig C. Hofmeister, MD, MPH

Craig C. Hofmeister, MD, MPH

Healthcare Professional
Associate Professor
Department of Hematology
and Medical Oncology
Emory University School of Medicine
201 Dowman Drive
Atlanta, Georgia, United States
Craig C. Hofmeister is Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.
 
Dr. Hofmeister earned his medical degree (MD) and his Master of Public Health (MPH) degree in clinical investigation from The Ohio State University in Columbus, Ohio. He completed his internship and hematology fellowship at Loyola University.
 
Dr. Hofmeister’s research focuses on early drug development and investigator-initiated clinical trials exploring novel diagnostics and treatments. As a translational researcher, he has been funded continuously from the National Cancer Institute (NCI) since 2016.
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close